CIPO Patents = 1

EPO Patents = 8

Forward Citations = 4

Loading Chart...

4 inventors (with patents filed for the assignee):

Greg Walker (4 out of 4 patents)

Renata Zbozien (2 out of 2 patents)

John Benjamin Nichols (1 out of 1 patent)

4. Sarah Margaret Middleton (1 out of 3 patents)

5. Alison Helena Goodall (0 patent)

6. Alison Helena Goodall (0 patent)

7. Sarah Margaret Taylor (0 patent)

8. Ben Nichols (0 patent)

9. Greg Walker (0 patent)

10. Alison Goodall (0 patent)

11. Greg Francis Walker (0 patent)

6 patents: Sort by Forward Citations

1. 11246958 - Haemostatic compositions (2022-02-15),

2. 10994047 - Peptide dendrimers comprising fibrinogen-binding peptides (2021-05-04),

3. 9913876 - Biogel (2018-03-13),

4. 9808553 - Haemostatic wound dressing (2017-11-07),

5. 9724379 - Therapeutic agents with improved fibrinogen binding (2017-08-08),

6. 9339584 - Biogel (2016-05-17),

Company Overview

Haemostatix Limited is a biotechnology company focused on developing innovative solutions for controlling bleeding in surgical and trauma settings. The company's proprietary technology platform enables the design of novel haemostatic agents that promote rapid and effective blood clotting. With a pipeline of promising product candidates, Haemostatix is dedicated to improving patient outcomes and reducing healthcare costs associated with managing bleeding complications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#25 in Nottingham

#2,680 in United Kingdom

Nottingham, United Kingdom

Haemostatix Limited

Forward Citations = 4

4 inventors:

Greg Walker (4 out of 4 patents)

Renata Zbozien (2 out of 2 patents)

John Benjamin Nichols (1 out of 1 patent)

4. Sarah Margaret Middleton (1 out of 3 patents)

5. Alison Helena Goodall (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Haemostatix Limited. Retrieved from https://idiyas.com/company/haemostatix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]